|
Prenatal alcohol exposure generates vulnerability to the proinflammatory effects of morphine and adverse neuroimmune consequences |
1R01AA029694-01 |
|
NIAAA |
2022 |
|
Craniofacial Morphogenesis in Prenatal Alcohol Exposure |
3R01AA011085-26S1 |
|
NIAAA |
2022 |
|
Prenatal alcohol/cannabinoid co-exposures and fetal brain development |
3R01AA028406-03S1 |
|
NIAAA |
2022 |
|
Prenatal alcohol exposure, GABAergic interneuron circuitry, early motor behavior, and the developing striatum |
5F30AA029261-02 |
|
NIAAA |
2022 |
|
Maternal Fetal Metabolic Disruption in Prenatal Alcohol Exposure |
5K99AA028291-02 |
|
NIAAA |
2022 |
|
Craniofacial Morphogenesis in Prenatal Alcohol Exposure |
5R01AA011085-26 |
|
NIAAA |
2022 |
|
FASD Inhibition of ASPH-Notch Mediates Adolescent Cerebral White Matter Pathology-Potential Utility of Non-invasive Extracellular Vesicle Assays |
5R01AA011431-23 |
|
NIAAA |
2022 |
|
A Novel Mechanistic Framework for FASD Etiology. |
5R01AA023520-09 |
|
NIAAA |
2022 |
|
Prenatal alcohol exposure and corticostriatal mediation of behavioral flexibility |
5R01AA025652-05 |
|
NIAAA |
2022 |
|
Prenatal Ethanol Exposure on Executive Function |
5R01AA026421-05 |
|
NIAAA |
2022 |